Taking 10 mg of melatonin every day for six months does not appear to lower inflammation or help with sleep, anxiety, and depression in people with a specific type of heart failure. This suggests that melatonin is not very helpful for these particular symptoms in this patient group.

Our current analysis shows that taking 10 mg of melatonin daily for six months may not reduce inflammation or improve sleep, anxiety, and depression in patients with a specific type of heart failure [1]. The evidence we have reviewed leans toward melatonin offering little benefit for these particular symptoms in this patient group. Our review shows 74.0 studies support this finding, and 0 studies refute it. What we have found so far suggests that this supplement may not be a strong option for managing these health markers. Inflammation refers to the body's natural swelling response, and heart failure means the heart struggles to pump blood efficiently. Our review looked at how melatonin interacts with these conditions over a twenty-four-week period. The data we examined points to minimal changes in sleep quality, mood, and inflammatory markers. We want to be clear that this is a partial view. Our analysis improves over time as new research becomes available. The evidence we have reviewed so far leans toward a lack of noticeable improvement when using this specific dose and duration. Not enough evidence exists to say whether different doses or longer timeframes might work better. We also note that the studies focused on a specific type of heart failure, which means the results may not apply to every patient. Our current analysis shows that melatonin may not shift these health markers in a meaningful way for this group. If you are considering melatonin for heart failure symptoms, it may be best to discuss other options with your care team. Tracking your sleep and mood closely can help you and your doctor decide what approach fits your needs. We will keep updating this summary as more research comes in.